Cite Filings / IMVT / 0001764013-26-000092

Feed Companies Filings Check

Sign in

DEF 14A

Proxy Statement

Immunovant, Inc. Filed 2026-07-22 Acc 0001764013-26-000092

Documents 1

DEF 14A Proxy Statement , imvt-20260721.htm

Around this filing

2026-07-24 4 Chief Technology Officer sold 2,857 shares at $38.69 ($110,537)
2026-07-24 4 Director sold 1,500 shares at $39.80 ($59,700)
2026-07-24 4 Chief Financial Officer sold 6,798 shares at $38.69 ($263,015)
2026-07-22 ARS Annual Report to Security Holders
2026-07-22 DEFA14A Proxy Materials
2026-07-22 DEF 14A Proxy Statement
2025-07-09 DEF 14A Proxy Statement

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)
SEC Structured Data (opens in new tab)

Loading imvt-20260721.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…